Ranked above it
Care Bare Rx
Tells you exactly what you're buying — but $199 is a starting point, not a rate.
#1 on our semaglutide provider ranking, above Vyvron at #107.
Read the Care Bare Rx review →
Provider review
Vyvron cost: $199 / 4 wks (about $216/mo) semaglutide
Line 3 of its live site is the developer's unfinished launch checklist.
The published HTML opens "=== VYVRON PRE-LAUNCH MODE ===" and lists what is still to do, including "Add Mississippi exclusion note to GLP-1 product section" — a state disclosure it knows is missing.
Verified August 2026
Reviewed by Marcus Webb
Transparency scorecard
2 of 4 disclosed openly
What Vyvron discloses about itself, read from its own pages — not estimated.
Pharmacy named & regulated
Not disclosed
Does not name a pharmacy or state a regulatory category anywhere on its own site.
State coverage published
Disclosed
Publishes which states it actually serves.
A real price is published
Disclosed
A real dollar figure is published on its own site, not estimated.
No hidden commitment trap
Not disclosed
The advertised price requires a prepay, auto-refill, or other commitment we found and named.
This review's stake, stated plainly — some of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
At a glance
Visit VyvronPharmacy
Not categorized
Labs
Not published as a requirement, cost or cadence.
States
Published state list
On this page
What it actually costs
$199 / 4 wks (about $216/mo)Semaglutide, per month
What this price covers
Medication
Included
Provider visits
Not confirmed
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
The catch — These are per-four-week rates presented as monthly, which is 13 charges a year rather than 12 — about $289 extra on tirzepatide. Its prepay tiers also mix calendar-month and four-week units, and neither prepay total appears in its own checkout catalog.
See plans at VyvronPrices read from Vyvron's own site · August 2026
What they advertise
Per four weeks: compounded semaglutide $199, tirzepatide $289, sermorelin $189, NAD+ $189, oral semaglutide $223, microdosed GLP-1 $149, B12-MIC $119. Prepay options at $790 per 12 weeks and $2,981 a year for tirzepatide.
What you actually pay
$199 per four weeks for compounded semaglutide, $289 tirzepatide, $189 sermorelin, $189 NAD+ — its own standing rates, distinct from the "founding" prices its marketing shows.
Money you will meet later
- Its "founding" prices are stated to return to higher figures — $199 to $249, $189 to $229, $149 to $179 — which match the underlying platform's base rates.
The bottom line
Vyvron sells compounded semaglutide at $199, tirzepatide at $289, sermorelin at $189 and NAD+ at $189, all billed per four weeks rather than per calendar month. It names four pharmacies and its clinical partner, OpenLoop, and covers all 50 states plus DC with Mississippi excluded for compounded products. But the site is not finished, and says so itself: the third line of its live HTML is a developer's pre-launch checklist that is still unticked, including an item to add the Mississippi exclusion to the GLP-1 section. Its "$199" start page also opens a checkout for tirzepatide at $289.
Vyvron appears on our semaglutide provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.
Who it is for, and who it is not
A good fit if
- You want the pharmacies named — it names four — and the clinical partner named too.
- You want sermorelin and NAD+ priced alongside the GLP-1s from one prescriber.
Look elsewhere if
- You are starting from its "$199" page — the button there opens a checkout for tirzepatide at $289.
- You budget by calendar month: its rates bill every four weeks, which is 13 charges a year rather than 12.
- You want to buy from a finished site — its own HTML still carries an unticked launch checklist, and its "100 of 100 founding spots left" counter is a hardcoded constant.
What Vyvron offers
Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.
Who fills your prescription
No category stated
Vyvron does not name the pharmacy that fills your prescription.
What its own site says
Named. Its pages name four — RedRock, Health Warehouse, Precision Medicine and Triad Rx — and name OpenLoop Healthcare Partners PC as the clinical group. Neither "503A" nor "503B" is stated for any of them.
What's the difference between 503A and 503B?
A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.
Where you can get it
Published state list
All 50 states plus DC, with Mississippi excluded for compounded products. A video visit is required in Arkansas, DC, Delaware, Kansas, Mississippi, New Mexico, Rhode Island and West Virginia.
The honest cons
The part they would rather you skipped
The third line of Vyvron's live homepage is a developer's note that was never removed. It opens "=== VYVRON PRE-LAUNCH MODE ===", states that "Site is in pre-launch mode," and lists what remains to be done on launch day — replacing the CTA links, changing the button text back, updating the FAQ answers "with confirmed OpenLoop content," and, in its own words, "Add Mississippi exclusion note to GLP-1 product section." That is a state-availability disclosure the company knows is missing from a page it is selling prescriptions on. The same checklist ends by reminding itself to "Confirm merchant descriptor shows Vyvron not OpenLoop." Around it: the "100 of 100 founding spots left" counter is a hardcoded constant with a full progress bar and no data behind it, the start page advertising $199 opens a checkout for tirzepatide at $289, and the homepage ships a block whose own comment says it is "visible to crawlers, ad-policy reviewers, and any no-JavaScript audit" while "this does NOT change what real visitors see" — that block carries no prices and no scarcity claims.
- The live HTML still contains an unticked pre-launch checklist, including an unmade Mississippi state disclosure — see this review's knock.
- Its start page advertises $199 and its button opens a checkout for tirzepatide at $289.
- The "100 of 100 founding spots left" counter is a hardcoded constant with no data behind it.
- It ships a block commented as visible to crawlers and ad-policy reviewers but not changing what real visitors see, carrying no prices and no scarcity.
- Rates bill every four weeks while presented as monthly — 13 charges a year.
- Neither "503A" nor "503B" is stated for any of the four pharmacies it names.
None of this is unique to Vyvron — the whole category shares it.
How it compares
The providers we rank on our semaglutide provider ranking — the most specific board Vyvron sits on — in the order that board ranks them. It sells into other categories too; see the boards listed above under the bottom line.
- Care Bare RxTells you exactly what you're buying — but $199 is a starting point, not a rate.
- Sesame CareA flat, medication-included semaglutide plan — tirzepatide works nothing like it.
- SnagRx"Locked-In... for Life" pricing sits beside a countdown claiming otherwise.
- Telos RxNames the states it can't serve — but the price you see probably isn't the real one.
- Sprout HealthNames both pharmacies and a real 44-state list — but every price is a starting floor.
- HealthRXStructured, disclosed pricing — but no legal entity is named anywhere on the site.
- Breeze MedsNames the exact compound in its nav — then hides the price behind a quiz.
- SkinnyRxInjectable and oral tirzepatide — but the advertised price is a floor, not what you pay.
153 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.
Ready to get started?
Prices and plans in this category change often — check Vyvron's current pricing before you decide. Ours was read from their own site in August 2026.
Facts on this page reflect Vyvron's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Vyvron's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.
Vyvron
$199 / 4 wks (about $216/mo) · Semaglutide